A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)
Clinical trial NCT05758402 · COMPLETED
Trial details
- NCT number
- NCT05758402
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-20
- Primary completion
- 2023-06-30
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.